Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.400 |
None |
1.000 |
12 |
|
1998 |
2016 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mental Retardation, Psychosocial
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
142
|
2
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Profound Mental Retardation
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
160
|
3
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mental deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
148
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
366
|
47
|
0.060 |
None |
1.000 |
6 |
|
1998 |
2017 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
disease |
|
Neoplastic Process
|
22
|
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2004 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
|
2011 |
2014 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2018 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Sarcopenia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
164
|
10
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Adult T Lymphoblastic Lymphoma
|
disease |
|
Neoplastic Process
|
21
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Childhood T Lymphoblastic Lymphoma
|
disease |
|
Neoplastic Process
|
21
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Precursor T-cell lymphoblastic lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
30
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
|
disease |
|
Disease or Syndrome
|
17
|
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2011 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1449
|
519
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2015 |
Post-traumatic amnesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
9
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2007 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |